MyBlueDotsHedia and Glooko Partner to Elevate Diabetes Management with Personalised Bolus Insulin Dosing MyBlueDots4 months ago01 mins COPENHAGEN, Denmark & PALO ALTO, Calif.–(BUSINESS WIRE)–Glooko and Hedia launched their interoperable solution, combining connected care, remote patient monitoring, and digital therapeutics for diabetes. Post navigation Previous: Azafaros granted important regulatory designations and clearance by European authorities for global Phase 3 studies, to be initiated in 2025Next: BOSTON ONCOLOGY ARABIA and SPIMACO Partner to Localize Advanced Oral Oncology Treatments in Saudi Arabia
Age-related genetic changes in the blood associated with poor cancer prognosis MyBlueDots2 days ago 0
TRIM63 identified as key gene in common heart disease, unlocking potential for earlier diagnosis MyBlueDots2 days ago 0
Newly discovered cells in connective tissue open up strategy against pancreatic cancer MyBlueDots2 days ago 0